External validation of a nomogram for identification of pathologically favorable disease in intermediate risk prostate cancer patients

The Prostate ◽  
2017 ◽  
Vol 77 (8) ◽  
pp. 928-933 ◽  
Author(s):  
Jean-Baptiste Beauval ◽  
Bastien Cabarrou ◽  
Giorgio Gandaglia ◽  
Pierre-Marie Patard ◽  
Adil Ouzzane ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Patients ◽  
External Validation ◽  
Intermediate Risk ◽  
Risk Prostate Cancer

scholarly journals Stratification of brachytherapy-treated intermediate-risk prostate cancer patients into favorable and unfavorable cohorts

2015 ◽  
Vol 6 ◽  
pp. 430-436 ◽  
Author(s):  
Gregory S. Merrick ◽  
Wayne M. Butler ◽  
Robert W. Galbreath ◽  
Ryan Fiano ◽  
Edward Adamovich
Keyword(s):  
Prostate Cancer ◽  
Cancer Patients ◽  
Intermediate Risk ◽  
Risk Prostate Cancer

Comparison between external beam radiotherapy (70Gy/74Gy) and permanent interstitial brachytherapy in 890 intermediate risk prostate cancer patients

2012 ◽  
Vol 103 (2) ◽  
pp. 223-227 ◽  
Author(s):  
Gregor Goldner ◽  
Richard Pötter ◽  
Jan J. Battermann ◽  
Christian Kirisits ◽  
Maximilian P. Schmid ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Patients ◽  
External Beam Radiotherapy ◽  
Interstitial Brachytherapy ◽  
External Beam ◽  
Intermediate Risk ◽  
Risk Prostate Cancer
Sign in / Sign up

Export Citation Format

Share Document